¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"principal value of strain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • normal value
    Á¤»óÄ¡, Á¤»ó°ª
  • positive predictive value
    ¾ç¼º¿¹ÃøÄ¡
  • predictive value
    ¿¹ÃøÄ¡
  • reference value
    ±âÁØÄ¡, ±âÁذª
  • resource based relative value scale
    ÀÚ¿ø±âÁØ»ó´ë°¡Ä¡µî±Þ
  • value
    °ª, °¡Ä¡, Ä¡
  • value system
    °¡Ä¡Ã¼°è
  • bacterial strain
    ¼¼±ÕÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ
  • diploid cell strain
    µÎ¹è¼öü¼¼Æ÷ÁÖ
  • eye strain
    ´«±äÀå
  • epidemic strain
    À¯Çà±ÕÁÖ
  • heterologous strain
    ÀÌÁ¾ÁÖ
  • hospital strain
    º´¿ø±ÕÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • correction value
    º¸Á¤Ä¡
  • crossover value
    ±³Â÷°ª
  • effective value
    À¯È¿°ª
  • end dilution value
    ü¿ÜÈñ¼®Ä¡
  • group reference value
    Áý´Ü±âÁØÄ¡
  • half-value layer
    ¹Ý°¡Ãþ
  • individualized reference value
    °³º°ÀûÂü°íÄ¡
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • molar buffer value
    ¸ô¿ÏÃæ°¡
  • normal value
    Á¤»óÄ¡
  • positive predictive value
    ¾ç¼º¿¹ÃøÄ¡
  • predictive value
    ¿¹ÃøÄ¡
  • resource based relative value scale
    Áö¿ø±âÁØ»ó´ë°¡Ä¡
  • spatial value
    °ø°£°¡
  • symbolic value
    »ó¡°¡Ä¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • group reference value
    Áý´Ü±âÁØ<--ÂüÁ¶>Ä¡
  • half value layer =HVL
    [¾È°ú]¹Ý°¡Ãþ(Úâʤöµ).
  • half-value layer
    ¹Ý°¡Ãþ
  • hematocrit value
    Ç츶ÅäÅ©¸®Æ®°ª.
  • hydrogen value
    ¼ö¼Ò°¡(â©áÈʤ).
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª.
  • individualized reference value
    °³º°Àû Âü°íÄ¡
  • positive predictive value (PPV)
    ¾ç¼º ¿¹ÃøÄ¡
  • postive predictive value
    ¾ç¼º ¿¹ÃøÄ¡
  • predictive value of control signal
    Á¦¾î<´ëÁ¶>½ÅÈ£ÀÇ ¿¹ÃøÄ¡
  • previous value check
    °ú°ÅÄ¡(ΦËÛö·)°Ë»ö(Ëþßã)
  • recombination value
    Àç°áÇÕ°ª.
  • Focal distance, principal
    ÃÊÁ¡(õ¥ïÇ)°Å¸®, ÁÖ¿ä(ñ«é©)
  • Focus, principal
    ÃÊÁ¡(õ¥ïÇ), ÁÖ¿ä(ñ«é©)
  • POMP (principal outer membrane protein)
    ÁÖ¿ä¿Ü¸·´Ü¹éÁú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • principal plane
    ÁÖ¸é(ñ«Øü).
  • principal point
    ÁÖÁ¡(ñ«ïÇ) ½ÃÃà(ãÊõî)ÀÇ .
  • principal point
    ÁÖÁ¡
  • principal quantum number
    ÁÖ¾çÀÚ¼ö(ñ«åÖ í­â¦).
  • principal reaction
    ÁÖ¹ÝÀÀ(ñ«Úãëë).
  • principal series
    ÁÖ°è¿­(̡˭Ëç).
  • principal stress
    ÁÖº¯Çü·Â, ÁÖÀÀ·Â(ñ«ëëæ³).
  • principal tangential line
    ÁÖÁ¢¼±°î¼±(ñ«ïÈàÊÍØàÊ).
  • principal valency
    ÁÖ¿øÀÚ°¡(ñ«ê«í­Ê¤).
  • bacterial strain
    ±ÕÁÖ(жñ»).
  • cell strain
    ¼¼Æ÷ÁÖ(á¬øàñ»)
  • cell strain
    ¼¼Æ÷ÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ(á¬øàñ»).
  • congeneic mouse strain
    ±Ø¼ÒÀÌÀ¯ÀüÀÚÇü ¸¶¿ì½º°è (¿¬¼Ó¿ª±³¹è·Î ¼±ÅõÈ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rough strain
    Á¶±ÕÁÖ(ðØÐ¶ñ»)
  • R strain
    R ±ÕÁÖ(жñ»)
  • smooth strain
    ÆòȰÁÖ(øÁüÁñ»)
  • S strain
    S ±ÕÁÖ(жñ»)
  • steric strain
    ÀÔü(Ø¡ô÷) ½ºÆ®·¹ÀÎ
  • strain
    "ÁÖ (ñ»), ½ºÆ®·¹ÀÎ"
  • stringent strain
    ¾ö°Ý ÁÖ (åñÌ«ñ»)
  • torsional strain
    ºñƲ¸² ½ºÆ®·¹ÀÎ
  • biological value
    »ý¹°°¡(ßæÚªÊ¤)
  • buffer value
    ¿ÏÃæ(èÐõú)°ª
  • caloric value
    Ä®·Î¸® °ª
  • Cot value
    Cot Ä¡(ö·)
  • C value
    C °ª
  • C value paradox
    C °ª ÆÄ¶óµ¶½º
  • dilution value of buffer
    ¿ÏÃæ¾× Èñ¼®°¡(èÐõúäûýüà·Ê¤)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
PMO postmenopausal osteoporosis; Principal Medical Officer
PND paroxysmal nocturnal dyspnea; partial neck dissection; postnasal drainage; postnasal drip; postnatal...
PNO Principal Nursing Officer
POMP phase-offset multiplanar [pulse sequence in magnetic resonance imaging]; principal outer material pr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PND principal Neutralizing Determinant
PND principal neutralizing domain
PO principal olive
HVL 6-half-value layer
BV Biological Value
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • absolute value
    Àý´ë °ª, Àý´ë Ä¡
    ½Ç¼ö¿¡¼­ ¾ç ¶Ç´Â À½ÀÇ ºÎÈ£¸¦ ¶¼¾î¹ö¸° ¼ö.
  • acid value
    »ê°ª, »ê°¡
    À¯Áö 1g¿¡ ÇÔÀ¯µÈ À¯¸® Áö¹æ»êÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ ¼ö»êÈ­Ä®·ýÀÇ §·¼ö¸¦ »ê°¡¶ó ÇÑ´Ù. À¯Áö´Â ¿À·¡ µÇ¸é À¯¸® Áö¹æ»êÀÌ Áõ°¡ÇϹǷΠ½Å¼±µµ µîÀÇ ±âÁØÀÌ µÈ´Ù. ½Ä¿ëÀ¯Áö´Â »ê°¡ 1 ÀÌÇÏÀÇ °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù°í ÇÑ´Ù.
  • average value
    Æò±ÕÄ¡
  • boundary value
    °æ°èÄ¡
  • correction value
    º¸Á¤Ä¡
  • fasting value
    °øº¹Ä¡
  • mean value
    Æò±ÕÄ¡
  • molar buffer value
    ¸ô ¿ÏÃæ°¡
  • negative predictive value
    À½¼º ¿¹»óÄ¡
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • observed value
    °üÃøÄ¡
  • osmotic value
    »ïÅõ °ª
  • symbolic value
    »ó¡ °¡Ä¡
  • threshold value
    ¿ªÄ¡
    ½Å°æÀ̳ª ±ÙÀ° µî¿¡ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â µ¥ ÇÊ¿äÇÑ ÃÖ¼Ò ÀÚ±Ø °ª. ÃÖ¼Ò ÇÑ°è °ªÀ̶ó°íµµ ÇÑ´Ù. ÀÛ¿ë ¿øÀο¡ µû¶ó ¿ªÄ¡ÀÇ Á¾·ùµµ ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ÀÚ±Ø ÀÛ¿ëÀÏ ¶§´Â ÀڱؿªÀ̶ó Çϰí, ±× Áß¿¡¼­µµ °¨°¢ Á¾·ù¿¡ µû¶ó ½Ã°¢¿ª, û°¢¿ªÀ̶ó°í ºÎ¸¥´Ù. ÀÌµé °ªÀº »ýü°¡ ÀÚ±ØÀ» ¹Þ¾Æ ÈïºÐÀ» ³ªÅ¸³»´Â ´É·Â, Áï ÈïºÐ¼ºÀÇ Ã´µµ·Î »ïÀ» ¼öµµ ÀÖ´Ù. ÀÚ±Ø È¿°ú´Â ±× °­µµ»Ó ¾Æ´Ï¶ó, ÀÚ±ØÀÇ Áö¼Ó ½Ã°£À̳ª °­µµÀÇ ½Ã°£Àû °æ°ú¿¡ µû¶ó Á¿ìµÈ´Ù. ¶Ç, ¼Ò¸®³ª ºû°ú °°ÀÌ ÀÛ¿ë ¿øÀÎÀÇ ¾çÀûÀÎ Â÷°¡ ÀÚ±Ø È¿°ú¿Í °°Àº °æ¿ì´Â ½Äº°¿ªÀ̶óµçÁö ±¸º°¿ªÀ̶ó Çϰí, ¾çÀûÀÎ Â÷¸¦ ¹®Á¦ ½ÃÇÏÁö ¾Ê´Â ÀÏ¹Ý ¿ªÄ¡¸¦ ´Ü¼ø¿ªÀ̶ó°í ÇÑ´Ù.
  • value judgement
    °¡Ä¡ ÆÇ´Ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cell strain <cell culture> Cells adapted to culture, but with finite division potential.
See: cell line.
(26 Mar 1998)
voice strain The development of hoarse voice secondary to overuse.
(27 Sep 1997)
rough strain <microbiology> Bacterial strains that have altered outer cell wall carbohydrate chains causing colonies on agar to change their appearance from smooth to dull.
In Streptococci the smooth strains are virulent whereas the rough strains are not. This is partly because the rough strains are much more readily phagocytosed.
(17 Dec 1997)
wild strain <virology> A viral strain found naturally, as opposed to one created in the laboratory.
(09 Oct 1997)
wild-type strain A strain found in nature or a standard strain.
See: auxotrophic strains, prototrophic strains.
(05 Mar 2000)
congenic strain An inbred strain of animals produced by continued crossing of a gene of one line onto another inbred (isogenic) line.
(05 Mar 2000)
muscle strain An acute tearing injury to muscle. Usually associated with a small amount of bleeding (haematoma) into the injured muscle tissue.
(27 Sep 1997)
crippled strain <microbiology> A strain of bacteria, typically highly pathogenic, that has been genetically engineered so that it cannot survive on anything but a veryspecialised medium of nutrients, this is done so that geneticists can experiment on certain pathogens without the risk that they will escape fromthe lab.
(09 Oct 1997)
HFR strain A strain, or clone, in which a conjugative plasmid (such as an F'), integrated in the bacterial genome, is instrumental in the transfer (along with plasmid DNA) of integrated bacterial DNA in a sequential manner to a suitable recipient.
Origin: high freguency of recombination
(05 Mar 2000)
pseudolysogenic strain A bacterial strain that is contaminated with a bacteriophage of low infectivity.
Synonym: pseudolysogenic strain.
(05 Mar 2000)
high frequency recombination strain A type of bacterial strain which is able to pass on genetic information to neighboring bacteria at a high rate. The high-frequency recombination strain (Hfr) is able to do this because it possesses the f plasmid and can therefore initiate bacterial conjugation.
(09 Oct 1997)
hypothetical mean strain A hypothetical strain that possesses the characteristics of a calculated mean organism.
(05 Mar 2000)
smooth strain <microbiology> Bacterial strains that have altered outer cell wall carbohydrate chains causing colonies on agar to change their appearance from smooth to dull.
In Streptococci the smooth strains are virulent whereas the rough strains are not. This is partly because the rough strains are much more readily phagocytosed.
(17 Dec 1997)
neotype strain A strain accepted by international agreement to replace a type strain which is no longer in existence or to serve as the type strain if a type strain was not designated and if no strain exists which can be designated as the type.
Synonym: neotype culture.
(05 Mar 2000)
stock strain A bacterial or other microbial strain that has been maintained under laboratory conditions as representative of its type.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • principal penalty
    ÁÖÇü
  • principal post
    Å« ±âµÕ;µ¿·®
  • principal rafter
    ÇÕ°¢
  • principal sentence
    ÁÖ¹®
  • principal sum
    (ÁöºÒµÇ´Â º¸Çè±ÝÀÇ)ÃÖ°í¾×
  • scarcity value
    Èñ¼Ò °¡Ä¡.
  • value
    °¡Ä¡,Æò°¡ÇÏ´Ù
  • R-value
    (resistance value)°ÇÃàÀç·áµîÀÇ ´Ü¿­¼º´ÉÄ¡
  • absolute value
    Àý´ë°ª
  • atomic value
    ¿øÀÚ°¡
  • atonic value
    ¿øÀÚ°¡
  • book value
    ÀåºÎ°¡°Ý
  • calorific value
    ¹ß¿­·®
  • cash (surrender) value
    ÇØ¾à ¹Ýȯ±Ý(º¸Çè °è¾à ÇØ¾à½Ã ¹ÝȯµÇ´Â ±Ý¾×)
  • exchange value
    (°æ)±³È¯ °¡Ä¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á